Department of Gastroenterological Surgery;
Aichi Cancer Center Hospital;
Division of Pharmacoproteomics;
National Cancer Center Research Institute;
Esophageal; cancer; Neoadjuvant; therapy; Response; prediction; Molecular; biomarker; Chemoradiation;